{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1045.31","meta":{"versionId":"18","lastUpdated":"2016-03-31T01:00:12.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.31","version":"20160331","name":"Other Anticoagulants for Acute Myocardial Infarction (AMI)","status":"active","date":"2016-03-31T01:00:12-04:00","publisher":"Lantana EH Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","concept":[{"code":"1037045","display":"dabigatran etexilate 150 MG Oral Capsule"},{"code":"1037179","display":"dabigatran etexilate 75 MG Oral Capsule"},{"code":"1114198","display":"rivaroxaban 10 MG Oral Tablet"},{"code":"1232082","display":"rivaroxaban 15 MG Oral Tablet"},{"code":"1232086","display":"rivaroxaban 20 MG Oral Tablet"},{"code":"1364435","display":"apixaban 2.5 MG Oral Tablet"},{"code":"1364445","display":"apixaban 5 MG Oral Tablet"},{"code":"1723476","display":"dabigatran etexilate 110 MG Oral Capsule"}]}]}}